|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1997-5-29
|
|
pubmed:abstractText |
We present the prospective economic evaluation that served as a secondary endpoint for the FIRST study, a randomized international multicenter trial of patients with severe congestive heart failure. Although the clinical results of this study were disappointing, we demonstrated the feasibility of incorporating prospective economic evaluation in phase III clinical trials.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0266-4623
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
698-713
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9136477-Aged,
pubmed-meshheading:9136477-Drug Evaluation,
pubmed-meshheading:9136477-Epoprostenol,
pubmed-meshheading:9136477-Health Care Costs,
pubmed-meshheading:9136477-Heart Failure,
pubmed-meshheading:9136477-Humans,
pubmed-meshheading:9136477-Multicenter Studies as Topic,
pubmed-meshheading:9136477-Platelet Aggregation Inhibitors,
pubmed-meshheading:9136477-Prospective Studies,
pubmed-meshheading:9136477-Quality-Adjusted Life Years,
pubmed-meshheading:9136477-Randomized Controlled Trials as Topic,
pubmed-meshheading:9136477-Regression Analysis
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Results of the economic evaluation of the first study. A multinational prospective economic evaluation. FIRST Investigators. Flolan International Randomized Survival Trial.
|
|
pubmed:affiliation |
Georgetown University Medical Center, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
